These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 34370408)

  • 1. A variant of Guillain-Barre syndrome after SARS-CoV-2 vaccination: AMSAN.
    Tutar NK; Eyigürbüz T; Yildirim Z; Kale N
    Ideggyogy Sz; 2021 Jul; 74(7-08):286-288. PubMed ID: 34370408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Guillain-Barré Syndrome In Association with SARS-CoV-2 Vaccination in Malaysia.
    Sii HL; Ng SH; Wong VF; Law WC
    Acta Neurol Taiwan; 2023 Dec; 32(4)():207-211. PubMed ID: 37723913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The First Guillain-Barr? Syndrome After SARS-CoV-2 Vaccination in Taiwan.
    Su SC; Lyu RK; Chang CW; Tseng WJ
    Acta Neurol Taiwan; 2022 Jan; 31(1)():46-51. PubMed ID: 34988954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
    Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
    Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
    Leung C
    Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillan-Barré Syndrome after First Vaccination Dose against COVID-19: Case Report.
    Čenščák D; Ungermann L; Štětkářová I; Ehler E
    Acta Medica (Hradec Kralove); 2021; 64(3):183-186. PubMed ID: 34779385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients.
    Kanabar G; Wilkinson P
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré Syndrome in an Elderly Patient as a Complication of COVID-19 Infection.
    Miyajan KF; Alyamani NA; Zafer DO; Tawakul AA
    Cureus; 2021 Oct; 13(10):e19154. PubMed ID: 34868787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of Guillain-Barré syndrome following COVID-19 vaccine.
    Hasan T; Khan M; Khan F; Hamza G
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34187803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute motor-sensory axonal polyneuropathy variant of Guillain-Barré syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism.
    Geng N; Wang P; Zhang Y
    Front Neurol; 2023; 14():1227505. PubMed ID: 37780717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
    J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine.
    Scendoni R; Petrelli C; Scaloni G; Logullo FO
    Hum Vaccin Immunother; 2021 Nov; 17(11):4093-4096. PubMed ID: 34347563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain Barre syndrome associated with coronavac vaccine. Report of one case].
    Wimmer Del-Solar J; Chávez-Martel P; Fontecilla-Villalobos E; Ibáñez-Rodríguez P; Rozas-Vidal JP
    Rev Med Chil; 2022 Jan; 150(1):125-130. PubMed ID: 35856975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination.
    Allen CM; Ramsamy S; Tarr AW; Tighe PJ; Irving WL; Tanasescu R; Evans JR
    Ann Neurol; 2021 Aug; 90(2):315-318. PubMed ID: 34114269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
    García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.